NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of RxSight, Inc. (NASDAQ: RXST) between November 7, 2024 and July 8, 2025. RxSight describes itself as a "commercial-stage medical technology company, engaged in the research and development, manufacture, and sale of light adjustable intraocular lenses.†For more information, submit a form, email attorney Phillip Kim, or gi. ...